114 related articles for article (PubMed ID: 19707223)
61. Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease.
Bravatà V
Int J Food Sci Nutr; 2015 Feb; 66(1):43-9. PubMed ID: 25318348
[TBL] [Abstract][Full Text] [Related]
62. Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
Kaya EF; Karakus N; Ulusoy AN; Özaslan C; Kara N
Oncol Res Treat; 2016; 39(9):534-8. PubMed ID: 27614738
[TBL] [Abstract][Full Text] [Related]
63. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
64. Association of Intake Folate and Related Gene Polymorphisms with Breast Cancer.
Chen X; Ahamada H; Zhang T; Bai Z; Wang C
J Nutr Sci Vitaminol (Tokyo); 2019; 65(6):459-469. PubMed ID: 31902858
[TBL] [Abstract][Full Text] [Related]
65. [C677T-SNP of methylenetetrahydrofolate reductase gene and breast cancer in Mexican women].
Calderón-Garcidueñas AL; Cerda-Flores RM; Castruita-Ávila AL; González-Guerrero JF; Barrera-Saldaña HA
Rev Med Inst Mex Seguro Soc; 2017; 55(6):720-724. PubMed ID: 29190865
[TBL] [Abstract][Full Text] [Related]
66. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.
Van Guelpen BR; Wirén SM; Bergh AR; Hallmans G; Stattin PE; Hultdin J
Eur J Cancer Prev; 2006 Feb; 15(1):46-50. PubMed ID: 16374229
[TBL] [Abstract][Full Text] [Related]
67. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
Nasr AS; Sami RM; Ibrahim NY
J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
[TBL] [Abstract][Full Text] [Related]
68. A high frequency of the MTHFR 677C>T polymorphism in Scottish women with epilepsy: possible role in pathogenesis.
Dean JC; Robertson Z; Reid V; Wang Q; Hailey H; Moore S; Rasalam AD; Turnpenny P; Lloyd D; Shaw D; Little J
Seizure; 2008 Apr; 17(3):269-75. PubMed ID: 17904392
[TBL] [Abstract][Full Text] [Related]
69. Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis.
Oppenheim EW; Adelman C; Liu X; Stover PJ
J Biol Chem; 2001 Jun; 276(23):19855-61. PubMed ID: 11278996
[TBL] [Abstract][Full Text] [Related]
70. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
71. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women.
Lee SA; Kang D; Nishio H; Lee MJ; Kim DH; Han W; Yoo KY; Ahn SH; Choe KJ; Hirvonen A; Noh DY
Exp Mol Med; 2004 Apr; 36(2):116-21. PubMed ID: 15150439
[TBL] [Abstract][Full Text] [Related]
72. Association Analysis of Methylenetetrahydrofolate Reductase Common Gene Polymorphisms with Breast Cancer Risk in an Iranian Population: A Case-Control Study and a Stratified Analysis.
Karimian M; Rezazadeh N; Khamehchian T
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2709-2714. PubMed ID: 32986372
[TBL] [Abstract][Full Text] [Related]
73. Association of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with primary glaucoma in Saudi population.
Al-Shahrani H; Al-Dabbagh N; Al-Dohayan N; Arfin M; Al-Asmari M; Rizvi S; Al-Asmari A
BMC Ophthalmol; 2016 Sep; 16(1):156. PubMed ID: 27585654
[TBL] [Abstract][Full Text] [Related]
74. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer.
Mu LN; Cao W; Zhang ZF; Yu SZ; Jiang QW; You NC; Lu QY; Zhou XF; Ding BG; Chang J; Chen CW; Wei GR; Cai L
Biomarkers; 2007; 12(1):61-75. PubMed ID: 17438654
[TBL] [Abstract][Full Text] [Related]
75. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR).
Sharp L; Little J; Schofield AC; Pavlidou E; Cotton SC; Miedzybrodzka Z; Baird JO; Haites NE; Heys SD; Grubb DA
Cancer Lett; 2002 Jul; 181(1):65-71. PubMed ID: 12430180
[TBL] [Abstract][Full Text] [Related]
76. Polymorphism C1420T of Serine hydroxymethyltransferase gene on maternal risk for Down syndrome.
Marucci GH; Zampieri BL; Biselli JM; Valentin S; Bertollo EM; Eberlin MN; Haddad R; Riccio MF; Vannucchi H; Carvalho VM; Pavarino EC
Mol Biol Rep; 2012 Mar; 39(3):2561-6. PubMed ID: 21687976
[TBL] [Abstract][Full Text] [Related]
77.
He L; Shen Y
Onco Targets Ther; 2017; 10():227-238. PubMed ID: 28123304
[TBL] [Abstract][Full Text] [Related]
78. Population-level diversity in the association of genetic polymorphisms of one-carbon metabolism with breast cancer risk.
Naushad SM; Divya C; Janaki Ramaiah M; Hussain T; Alrokayan SA; Kutala VK
J Community Genet; 2016 Oct; 7(4):279-290. PubMed ID: 27541683
[TBL] [Abstract][Full Text] [Related]
79. Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility.
Kumar P; Yadav U; Rai V
Meta Gene; 2015 Dec; 6():72-84. PubMed ID: 26629412
[TBL] [Abstract][Full Text] [Related]
80. MTHFR 677C>T polymorphism and the risk of breast cancer: evidence from an original study and pooled data for 28031 cases and 31880 controls.
Pooja S; Carlus J; Sekhar D; Francis A; Gupta N; Konwar R; Kumar S; Kumar S; Thangaraj K; Rajender S
PLoS One; 2015; 10(3):e0120654. PubMed ID: 25803740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
